Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Small Cell Lung Cancer Clinical Trials

A listing of Small Cell Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (167) clinical trials

Cardiopulmonary Toxicity of Thoracic Radiotherapy

In the present study, the incidence and time course of treatment-related changes in cardio-pulmonary physiology will be assessed using standard diagnostic tools such as echocardiography, cardiac MRI (CMR) and serum biomarkers and relate them to the radiation dose distribution. Such insight in the characteristics of this possible radiation-induced PH and ...

Phase N/A

DOTATOC PET/CT for Imaging NET Patients

Each subject will have two PET/CT scans, one using 68Ga-DOTATOC and the other using 18-Fluoride-Fluorodeoxyglucose (18F-FDG). The 68Ga-DOTATOC radioactive tracer is manufactured for this study under a Clinical Trial Application filed with Health Canada. 18F-FDG is considered standard care and has been approved by Health Canada. After providing informed written ...

Phase N/A

Registry of Guardant360 Use and Outcomes In People With Advanced Cancer

This is a prospective, descriptive registry of people with advanced cancer for whom a Guardant360 assay has been ordered by their health care providers. The registry is divided into modules according to primary cancer diagnosis. Module 1 includes subjects with advanced NSCLC with additional modules added later in the study. ...

Phase N/A

Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA

A central challenge in the fight against lung cancers is how to detect disease in a noninvasive manner before it is detectable by imaging methods. Although inroads have been made with more sensitive imaging techniques for earlier detection of breast and lung cancers, these techniques are limited by the size ...

Phase N/A

Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study

Current guidelines in non-small cell lung cancer recommend genomic assessment for mutations in EGFR and BRAF, gene rearrangements in ALK and ROS1, and resistance mutations such as T790M upon progression during EGFR inhibitor therapy. However, obtaining sufficient tumour tissue to test for these molecular alterations, as well as those with ...

Phase N/A

Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS

Primary objective: To assess safety of the study drug for EGFR-tyrosine kinase inhibitor (TKI) nave patients with locally advanced or metastatic, EGFR exon 19 deletions or exon 21 (L858R) substitution mutation-positive NSCLC, patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC who have been previously treated with EGFR TKI ...

Phase N/A

Safety and Efficacy of Lorbrena

To investigate the following matters under post-marketing use of Lorbrena in patients who received this drug Factors affecting the onset of central nervous system disorder Effect of Lorbrena in combination with CYP3A inducers on the onset of hepatic dysfunction

Phase N/A